DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
HZT-501 is an investigational drug.
There have been 4 clinical trials for HZT-501. The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2007.
The most common disease conditions in clinical trials are Arthritis, Rheumatoid, Osteoarthritis, and Nociceptive Pain. The leading clinical trial sponsors are Horizon Pharma Ireland, Ltd., Dublin Ireland and [disabled in preview].
Recent Clinical Trials for HZT-501
|Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug Treatment||Horizon Pharma Ireland, Ltd., Dublin Ireland||Phase 3|
|Double-Blind Follow-on Safety Study of HZT-501 (Ibuprofen 800 mg/Famotidine 26.6 mg) in Subjects Who Have Completed Participation in HZ-CA-301 (NCT00450658) or HZ-CA-303 (NCT00450216)||Horizon Pharma Ireland, Ltd., Dublin Ireland||Phase 3|
|Efficacy and Safety Study of HZT-501 in Subjects Requiring Nonsteroidal Anti-Inflammatory Drug (NSAID) Treatment||Horizon Pharma Ireland, Ltd., Dublin Ireland||Phase 3|